MLC fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Malin Corp. Plc. invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. Its priority assets includes Poseida, Immunocore, Kymab and Viamet. The company was founded on December 16, 2014 and is headquartered in Dublin, Ireland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
MLC does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company